昊海生科
(688366)
| 流通市值：100.83亿 | | | 总市值：120.85亿 |
| 流通股本：1.94亿 | | | 总股本：2.33亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,304,402,771.08 | 618,542,128.87 | 2,697,657,908.35 | 2,074,811,249.42 |
| 营业收入 | 1,304,402,771.08 | 618,542,128.87 | 2,697,657,908.35 | 2,074,811,249.42 |
| 二、营业总成本 | 1,060,135,756.55 | 510,997,863.52 | 2,243,948,641.01 | 1,699,560,309.6 |
| 营业成本 | 389,133,681.64 | 188,523,965.56 | 812,626,479.75 | 613,788,582.06 |
| 税金及附加 | 6,559,102.02 | 2,143,394.55 | 17,546,424.75 | 11,992,211.91 |
| 销售费用 | 392,384,200.56 | 193,890,188.65 | 780,848,897.96 | 594,490,949.81 |
| 管理费用 | 204,544,577.76 | 88,230,167.79 | 442,700,593.26 | 325,236,112.34 |
| 研发费用 | 98,400,954.44 | 48,418,019.42 | 238,929,301.47 | 188,136,393.76 |
| 财务费用 | -30,886,759.87 | -10,207,872.45 | -48,703,056.18 | -34,083,940.28 |
| 其中:利息费用 | 5,698,815.86 | 2,520,367.46 | 18,061,010.12 | 8,977,793.9 |
| 其中:利息收入 | 33,090,787.1 | 13,672,758.05 | 73,961,580 | 54,883,656.75 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 641,458.51 | 117,883.95 | 25,915,335.3 | -345,330.26 |
| 加:投资收益 | -28,716.01 | -81,191.87 | 1,002,272.17 | 96,833.95 |
| 资产处置收益 | 463,706.57 | 359,499.7 | -16,481.37 | 217,985.29 |
| 资产减值损失(新) | -14,816,147.41 | -6,593,823.48 | -32,238,397.56 | -13,132,183.94 |
| 信用减值损失(新) | -2,165,972.65 | 22,975.45 | 2,229,268.12 | 306,860.88 |
| 其他收益 | 7,907,255.52 | 2,437,251.71 | 44,160,167.51 | 25,135,964.94 |
| 四、营业利润 | 236,268,599.06 | 103,806,860.81 | 494,761,431.51 | 387,531,070.68 |
| 加:营业外收入 | 59,440.51 | 49,064.39 | 988,310.02 | 252,513.63 |
| 减:营业外支出 | 697,802.78 | 528,616.56 | 29,604,284.75 | 1,343,144.88 |
| 五、利润总额 | 235,630,236.79 | 103,327,308.64 | 466,145,456.78 | 386,440,439.43 |
| 减:所得税费用 | 33,964,612.39 | 19,516,420.06 | 89,902,154.56 | 70,457,746.73 |
| 六、净利润 | 201,665,624.4 | 83,810,888.58 | 376,243,302.22 | 315,982,692.7 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 201,665,624.4 | 83,810,888.58 | 376,243,302.22 | 315,982,692.7 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 211,065,253.9 | 90,312,072.67 | 420,446,906.16 | 340,889,084.77 |
| 少数股东损益 | -9,399,629.5 | -6,501,184.09 | -44,203,603.94 | -24,906,392.07 |
| 扣除非经常损益后的净利润 | 204,205,290.01 | 88,474,729.61 | 379,096,331.64 | 321,415,988.63 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.91 | 0.39 | 1.8 | 1.46 |
| (二)稀释每股收益 | 0.91 | 0.39 | 1.8 | 1.46 |
| 八、其他综合收益 | 50,146,873.86 | 22,479,538.35 | -110,792,943.52 | 2,257,044.78 |
| 归属于母公司股东的其他综合收益 | 41,012,681.05 | 19,212,366.52 | -111,550,239.01 | -1,271,933.14 |
| 九、综合收益总额 | 251,812,498.26 | 106,290,426.93 | 265,450,358.7 | 318,239,737.48 |
| 归属于母公司股东的综合收益总额 | 252,077,934.95 | 109,524,439.19 | 308,896,667.15 | 339,617,151.63 |
| 归属于少数股东的综合收益总额 | -265,436.69 | -3,234,012.26 | -43,446,308.45 | -21,377,414.15 |
| 公告日期 | 2025-08-23 | 2025-04-26 | 2025-03-22 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |